- Home
- DCX vs BDRX Comparison
DCX vs BDRX Comparison
Compare DCX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCX | BDRX |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 1.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DCX | BDRX |
|---|---|---|
| Price | $3.37 | $2.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 50.5K | ★ 316.1K |
| Earning Date | 03-24-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,107,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.00 | $2.03 |
| 52 Week High | $3,432.00 | $92.00 |
Technical Indicators
Market Signals| Indicator | DCX | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.38 | 37.83 |
| Support Level | $0.35 | $2.03 |
| Resistance Level | $5.68 | $2.27 |
| Average True Range (ATR) | 0.40 | 0.14 |
| MACD | 0.33 | 0.09 |
| Stochastic Oscillator | 51.88 | 13.23 |
Price Performance
Historical ComparisonAbout DCX Digital Currency X Technology Inc. Class A Ordinary Shares
Digital Currency X Technology Inc, formerly Chijet Motor Company Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.